25th ECNP Congress (European College of Neuropsychopharmacology)

Please find below the provisional topics of the scientific programme.

Addiction
GABA modulation of dopamine mesolimbic system in addiction: from bench to bedside (pc)
Genetic and functional dissection of dopaminergic pathway functions (pr)
Pathological gambling: an addiction, but how to treat it? Insights from pre-clinical, clinical neuroimaging and treatment studies (ct)

Affective disorders and antidepressants
Moving biology forward in bipolar disorder (cr)
New mechanisms and novel therapeutics: how recent discoveries are opening perspectives for targeting serotonin 5-HT1A receptor function (pc)
Roles of orexin and melanin-concentrating hormone (MCH) in affective disorders and their comorbid conditions: evidence from animal models (cr)
TEM 2011 Affective Disorders and Antidepressants symposium

Anxiety disorders and anxiolytics
Social anxiety disorder (SAD): from the clinic to the laboratory and backwards (cr)
The stressed amygdala: from microcircuitry to anxiety (ct)
TEM 2011 Anxiety Disorders and Anxiolytics symposium

Basic and clinical neuroscience
Glutamate co-transmission in brain: where, when, how, what for? (pr)
Mining the metabotropic glutamate receptors type 4 (mGLUR4) and their ligands in brain disorders (pr)
The immune - brain axis: a concept gaining momentum (pr)
Updates in molecular findings in child and adolescent psychiatry (pr)
TEM 2011 Basic and Clinical Neuroscience symposium

Child and adolescent disorders and treatment
Cross-species insights on the neurobiology of cognitive flexibility (pr)
The ENI child and adolescent network: recent achievements (ct)
New data on ADHD (cr)

Dementia and neurological disorders
Immunotherapy in neurodegenerative disorders (ct)
Patient-specific neuronal stem cells: a novel translational tool to study CNS diseases (pc)
Understanding pathophysiology of CNS neurodegenerative diseases: from pathology to neuroimaging findings (cr)
TEM 2011 Dementia symposium

Psychotic disorders and antipsychotics
Challenging diagnostic boundaries in psychiatry: will research findings change psychiatric nosology? (cr)
Cognitive remediation and cognitive enhancement in schizophrenia - making the most of both of therapies? (ct)
Drugs as tools in neuropsychiatry: ketamine (cr)

Other
Deep brain stimulation (DBS) in psychiatry: a decade of experience (ct)
Young Scientists Award symposium 1 (pr)
Young Scientists Award symposium 2 (pc)